Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure

Obesity

Volumn 21, Issue 9, 2013, Pages

  Ballo, Piercarlo ^a   Betti, Irene ^a   Barchielli, Alessandro ^b   Castelli, Gabriele ^c   De Luca, Leonardo ^d   Gheorghiade, Mihai ^e   Zuppiroli, Alfredo ^b  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b Local Health Unit   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d EUROPEAN HOSPITAL   (Italy)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; SURVIVAL;

AGED; BODY MASS INDEX; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROGNOSIS; RISK; SEX FACTORS;

EID: 84884855727     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20420     Document Type: Article

References (40)

1. Djoussé L, Bartz TM, Ix JH, Zieman SJ, Delaney JA, Mukamal KJ, et al. Adiposity and incident heart failure in older adults: the cardiovascular health study. Obesity 2012; 20: 1936-1941.
2. Andreotti F, Rio T, Lavorgna A,. Body fat and cardiovascular risk: understanding the obesity paradox. Eur Heart J 2009; 30: 752-754.
3. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA,. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008; 156: 13-22.
4. Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S,. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 2010; 123: 646-651.
5. Benderly M, Boyko V, Goldbourt U,. Relation of body mass index to mortality among men with coronary heart disease. Am J Cardiol 2010; 106: 297-304.
6. Sohn MW, Budiman-Mak E, Oh EH, Park MS, Stuck RM, Stone NJ, et al. Obesity paradox in amputation risk among nonelderly diabetic men. Obesity 2012; 20: 460-462.
7. Johnson NP, Wu E, Bonow RO, Holly TA,. Relation of exercise capacity and body mass index to mortality in patients with intermediate to high risk of coronary artery disease. Am J Cardiol 2008; 102: 1028-1033.
8. Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010; 31: 222-226.
9. Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ,. All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis 1986; 29: 29-54.
10. Wassertheil-Smoller S, Fann C, Allman RM, Black HR, Camel GH, Davis B, et al. SHEP Cooperative Research Group Relation of low body mass to death and stroke in the Systolic Hypertension in the Elderly Program. Arch Intern Med 2000; 160: 494-500.
11. Lea JP, Crenshaw DO, Onufrak SJ, Newsome BB, McClellan WM,. Obesity, end-stage renal disease, and survival in an elderly cohort with cardiovascular disease. Obesity 2009; 17: 2216-2222.
12. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med 2006; 173: 79-83.
13. Escalante A, Haas RW, del Rincõn I,. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005; 165: 1624-1629.
14. Majer IM, Nusselder WJ, Mackenbach JP, Kunst AE,. Life expectancy and life expectancy with disability of normal weight, overweight, and obese smokers and nonsmokers in Europe. Obesity 2011; 19: 1451-1459.
15. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005; 165: 55-61.
16. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M,; ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007; 153: 74-81.
17. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, et al. Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 2009; 104: 1116-1121.
18. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009; 53: e1-e90.
19. Heitmann BL, Hills AP, Frederiksen P, Ward LC,. Obesity, leanness, and mortality: effect modification by physical activity in men and women. Obesity 2009; 17: 136-142.
20. Poobalan AS, Aucott LS, Smith WC, Avenell A, Jung R, Broom J,. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev 2007; 8: 503-513.
21. Wilsgaard T, Jacobsen BK, Mathiesen EB, Njolstad I,. Weight loss and mortality: a gender-specific analysis of the Tromso study. Gend Med 2009; 6: 575-586.
22. Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail 2009; 15: 377-384.
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
24. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Org: Geneva, 1999.
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
26. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193.
27. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268.
28. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
29. Goh VL, Wakeham MK, Brazauskas R, Mikhailov TA, Goday PS,. Obesity is not associated with increased mortality and morbidity in critically ill children. JPEN J Parenter Enteral Nutr 2013; 37: 102-108.
30. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G,. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010; 340: c1240.
31. Stamler R, Ford CE, Stamler J,. Why do lean hypertensive patients have higher mortality rates than other hypertensive patients? (Findings of the Hypertension Detection and Follow-up Program). Hypertension 1991; 17: 553-564.
32. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120: 863-870.
33. Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, et al. Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail 2011; 13: 200-206.
34. Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F,. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011; 107: 412-416.
35. Guida B, Laccetti R, Procino A, Memoli B,. "Obesity paradox" or a better nutritional status? Am J Med 2008; 121: e7.
36. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL,. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST). Circulation 2001; 103: 2055-2059.
37. Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J,. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension. J Hypertens 2008; 26: 2168-2175.
38. Wai WS, Dhami RS, Gelaye B, Girma B, Lemma S, Berhane Y, et al. Comparison of measures of adiposity in identifying cardiovascular disease risk among Ethiopian adults. Obesity 2012; 20: 1887-1895.
39. Barrios V, Escobar C, Calderõn A,. Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMI. Obesity 2010; 18: 2017-2022.
40. Habbu A, Lakkis NM, Dokainish H,. The obesity paradox: fact or fiction? Am J Cardiol 2006; 98: 944-948.